Evidence map›Paper›PMID 30068108›Full record

ArticleThe Review of scientific instruments2018

A new preclinical ultrasound platform for widefield 3D imaging of rodents.

Tomasz J Czernuszewicz, Virginie Papadopoulou, Juan D Rojas, Rajalekha M Rajamahendiran, Jonathan Perdomo, James Butler, Max Harlacher, Graeme O'Connell, Dženan Zukić, Stephen R Aylward and 2 more

Abstract readValidation Study
In one paragraph

Article in The Review of scientific instruments, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Noninvasive Monitoring of Steatotic Liver Disease in Western Diet-Fed Obese Mice Using Automated Ultrasound and Shear Wave Elastography.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tomasz J CzernuszewiczSonoVol, Inc., Research Triangle Park, North Carolina 27709, USA.ORCID 0000000254934058
Virginie PapadopoulouJoint Department of Biomedical Engineering, The University of North Carolina and North Carolina State University, Chapel Hill, North Carolina 27599, USA.ORCID 0000000333953003
Juan D RojasJoint Department of Biomedical Engineering, The University of North Carolina and North Carolina State University, Chapel Hill, North Carolina 27599, USA.
Rajalekha M RajamahendiranSonoVol, Inc., Research Triangle Park, North Carolina 27709, USA.
Jonathan PerdomoSonoVol, Inc., Research Triangle Park, North Carolina 27709, USA.
James ButlerSonoVol, Inc., Research Triangle Park, North Carolina 27709, USA.
Max HarlacherSonoVol, Inc., Research Triangle Park, North Carolina 27709, USA.
Graeme O'ConnellSonoVol, Inc., Research Triangle Park, North Carolina 27709, USA.
Dženan ZukićKitware, Inc., Carrboro, North Carolina 27510, USA.ORCID 0000000295469703
Stephen R AylwardKitware, Inc., Carrboro, North Carolina 27510, USA.ORCID 0000000278628856
Paul A DaytonJoint Department of Biomedical Engineering, The University of North Carolina and North Carolina State University, Chapel Hill, North Carolina 27599, USA.
Ryan C GessnerSonoVol, Inc., Research Triangle Park, North Carolina 27709, USA.

Funding

Quantitative Ultrasound Analysis of Vascular Morphology for Cancer AssessmentR44CA165621 · NCI · KITWARE, INC. · PI AYLWARD, STEPHEN R, DAYTON, PAUL A · 2015 to 2016
$1.3M
Novel Ultrasound Molecular Imaging for Assessment of Tumor Response to TherapyF31CA196216 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROJAS, JUAN DAVID · 2015 to 2017
$97k
NCI NIH HHS F31 CA196216NCI NIH HHS R44 CA165621
6 · The paper itself

Abstract

Noninvasive in vivo imaging technologies enable researchers and clinicians to detect the presence of disease and longitudinally study its progression. By revealing anatomical, functional, or molecular changes, imaging tools can provide a near real-time assessment of important biological events. At the preclinical research level, imaging plays an important role by allowing disease mechanisms and potential therapies to be evaluated noninvasively. Because functional and molecular changes often precede gross anatomical changes, there has been a significant amount of research exploring the ability of different imaging modalities to track these aspects of various diseases. Herein, we present a novel robotic preclinical contrast-enhanced ultrasound system and demonstrate its use in evaluating tumors in a rodent model. By leveraging recent advances in ultrasound, this system favorably compares with other modalities, as it can perform anatomical, functional, and molecular imaging and is cost-effective, portable, and high throughput, without using ionizing radiation. Furthermore, this system circumvents many of the limitations of conventional preclinical ultrasound systems, including a limited field-of-view, low throughput, and large user variability.

Indexed as

RodentiaAnimalsCarcinoma, Renal CellCell Line, TumorContrast MediaDisease ProgressionEquipment DesignFemaleHemangiosarcomaHumansImaging, Three-DimensionalLongitudinal StudiesMicrobubblesNeoplasm TransplantationObserver VariationPilot ProjectsContrast Media

Identifiers

PMID30068108
PMCPMC6045495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.